Faheem Maqbool
School of Pharmacy, Pharmacy Australia Centre of Excellence, University of Queensland, Brisbane, QLD 4102, Australia
Amman Abid
Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan
Ishtiaq Ahmed
School of Medical Science, Gold coast campus, Griffith University, Southport QLD 4222, Australia
International Journal of Pharmacology
Year: 2017 | Volume: 13 | Issue: 7 | Page No.: 773-784
PDF Fulltext XML References Citation
How to cite this article
Faheem Maqbool, Amman Abid and Ishtiaq Ahmed, 2017. Drug Discovery Processes to Drug Targeting Mechanisms. International Journal of Pharmacology, 13: 773-784.
DOI: 10.3923/ijp.2017.773.784
URL: https://scialert.net/abstract/?doi=ijp.2017.773.784
DOI: 10.3923/ijp.2017.773.784
URL: https://scialert.net/abstract/?doi=ijp.2017.773.784
Comments
Leave a Comment
Your email address will not be published. Required fields are marked *
Article Trend
Total views 3326
References
- Maqbool, F., H. Bahadar and M. Abdollahi, 2014. Science for the benefits of all: The way from idea to product. J. Med. Hypotheses Ideas, 8: 74-77.
CrossRefDirect Link - Hughes, J.P., S. Rees, S.B. Kalindjian and K.L. Philpott, 2011. Principles of early drug discovery. Br. J. Pharmacol., 162: 1239-1249.
CrossRefDirect Link - Chin, Y.W., M.J. Balunas, H.B. Chai and A.D. Kinghorn, 2006. Drug discovery from natural sources. AAPS J., 8: E239-E253.
CrossRefPubMedDirect Link - Zhang, M.Q. and B. Wilkinson, 2007. Drug discovery beyond the 'rule-of-five'. Curr. Opin. Biotechnol., 18: 478-488.
CrossRefDirect Link - Cragg, G.M. and D.J. Newman, 2005. Biodiversity: A continuing source of novel drug leads. Pure Appl. Chem., 77: 7-24.
CrossRefDirect Link - Gupta, P. and K.H. Lee, 2007. Genomics and proteomics in process development: opportunities and challenges. Trends Biotechnol., 25: 324-330.
CrossRefDirect Link - Ahn, N.G. and A.H.J. Wang, 2008. Proteomics and genomics: Perspectives on drug and target discovery. Curr. Opin. Chem. Biol., 12: 1-3.
CrossRefDirect Link - Lee, J.A., M.T. Uhlik, C.M. Moxham, D. Tomandl and D.J. Sall, 2012. Modern phenotypic drug discovery is a viable, neoclassic pharma strategy. J. Med. Chem., 55: 4527-4538.
CrossRefDirect Link - Swinney, D.C. and J. Anthony, 2011. How were new medicines discovered? Nat. Rev. Drug Discov., 10: 507-519.
CrossRefDirect Link - Dolle, R.E., 2001. Comprehensive survey of combinatorial library synthesis: 2000. J. Comb. Chem., 3: 477-517.
CrossRefDirect Link - Drews, J., 2000. Drug discovery: A historical perspective. Science, 287: 1960-1964.
CrossRefDirect Link - Newman, D.J., G.M. Cragg and K.M. Snader, 2000. The influence of natural products upon drug discovery. Natl. Prod. Rep., 17: 215-234.
CrossRefPubMedDirect Link - Lombardino, J.G. and J.A. Lowe, 2004. The role of the medicinal chemist in drug discovery-then and now. Nat. Rev. Drug Discov., 3: 853-862.
CrossRefDirect Link - Gershell, L.J. and J.H. Atkins, 2003. A brief history of novel drug discovery technologies. Nat. Rev. Drug Discov., 2: 321-327.
CrossRefDirect Link - Dudzinski, D.M. and A.S. Kesselheim, 2008. Scientific and legal viability of follow-on protein drugs. N. Engl. J. Med., 358: 843-849.
CrossRefPubMedDirect Link - Tucker, J., S. Yakatan and S. Yakatan, 2008. Biogenerics 2007: How far have we come? J. Commer. Biotechnol., 14: 56-64.
CrossRefDirect Link - Qadir, M.I. and A. Abid, 2017. Acute HIV infection: Advances in mechanisms and prophylactic therapeutic management. Crit. Rev. Eukaryotic Gene Express., 27: 79-90.
CrossRefDirect Link - Triggle, D.J., 2006. Drug discovery and delivery in the 21st century. Med. Principles Pract., 16: 1-14.
CrossRefDirect Link - Yang, Y., S.J. Adelstein and A.I. Kassis, 2009. Target discovery from data mining approaches. Drug Discov. Today, 14: 147-154.
CrossRefDirect Link - Bertram, L. and R.E. Tanzi, 2008. Thirty years of Alzheimer's disease genetics: The implications of systematic meta-analyses. Nat. Rev. Neurosci., 9: 768-778.
CrossRefDirect Link - Cox, J.J., F. Reimann, A.K. Nicholas, G. Thornton and E. Roberts et al., 2006. An SCN9A channelopathy causes congenital inability to experience pain. Nature, 444: 894-898.
CrossRefDirect Link - Yang, Y., Y. Wang, S. Li, Z. Xu and H. Li et al., 2004. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J. Med. Genet., 41: 171-174.
CrossRefDirect Link - Kurosawa, G., Y. Akahori, M. Morita, M. Sumitomo and N. Sato et al., 2008. Comprehensive screening for antigens overexpressed on carcinomas via isolation of human mAbs that may be therapeutic. Proc. Natl. Acad. Sci. USA., 105: 7287-7292.
CrossRefDirect Link - Honore, P., K. Kage, J. Mikusa, A.T. Watt and J.F. Johnston et al., 2002. Analgesic profile of intrathecal P2X3 antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats. Pain, 99: 11-19.
CrossRefDirect Link - Chessell, I.P., J.P. Hatcher, C. Bountra, A.D. Michel and J.P. Hughes et al., 2005. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain, 114: 386-396.
CrossRefDirect Link - Abell, A.N., J.A. Rivera-Perez, B.D. Cuevas, M.T. Uhlik and S. Sather et al., 2005. Ablation of MEKK4 kinase activity causes neurulation and skeletal patterning defects in the mouse embryo. Mol. Cell. Biol., 25: 8948-8959.
CrossRefDirect Link - Castanotto, D. and J.J. Rossi, 2009. The promises and pitfalls of RNA-interference-based therapeutics. Nature, 457: 426-433.
CrossRefDirect Link - Whitehead, K.A., R. Langer and D.G. Anderson, 2009. Knocking down barriers: Advances in siRNA delivery. Nat. Rev. Drug Discov., 8: 129-138.
CrossRefDirect Link - Ugolini, G., S. Marinelli, S. Covaceuszach, A. Cattaneo and F. Pavone, 2007. The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain. Proc. Natl. Acad. Sci. USA., 104: 2985-2990.
CrossRefDirect Link - Zanders, E.D., D.S. Bailey and P.M. Dean, 2002. Probes for chemical genomics by design. Drug Discov. Today, 7: 711-718.
CrossRefDirect Link - Fox, S., S. Farr-Jones, L. Sopchak, A. Boggs, H.W. Nicely, R. Khoury and M. Biros, 2006. High-throughput screening: update on practices and success. J. Biomol. Screening, 11: 864-869.
CrossRefDirect Link - Boppana, K., P.K. Dubey, S.A.R.P. Jagarlapudi, S. Vadivelan and G. Rambabu, 2009. Knowledge based identification of MAO-B selective inhibitors using pharmacophore and structure based virtual screening models. Eur. J. Med. Chem., 44: 3584-3590.
CrossRefDirect Link - McInnes, C., 2007. Virtual screening strategies in drug discovery. Curr. Opin. Chem. Biol., 11: 494-502.
CrossRefDirect Link - Frearson, J.A. and I.T. Collie, 2009. HTS and hit finding in academia-from chemical genomics to drug discovery. Drug Discov. Today, 14: 1150-1158.
CrossRefDirect Link - Drake, J.M. and B.D. Griffen, 2010. Early warning signals of extinction in deteriorating environments. Nature, 467: 456-459.
CrossRefDirect Link - Maqbool, F., S. Mostafalou, H. Bahadar and M. Abdollahi, 2016. Review of endocrine disorders associated with environmental toxicants and possible involved mechanisms. Life Sci., 145: 265-273.
CrossRefDirect Link - Eichler, H.G., B. Aronsson, E. Abadie and T. Salmonson, 2010. New drug approval success rate in Europe in 2009. Nat. Rev. Drug Discov., 9: 355-356.
CrossRefDirect Link - Brown, M.J., 2009. The impact of clinical trials legislation on clinical pharmacology: Problems and solutions. Br. J. Clin. Pharmacol., 67: 487-493.
CrossRefDirect Link - Sherman, R.E., J. Li, S. Shapley, M. Robb and J. Woodcock, 2013. Expediting drug development-the FDA's new breakthrough therapy designation. N. Engl. J. Med., 369: 1877-1880.
CrossRefDirect Link - Michelini, E., L. Cevenini, L. Mezzanotte, A. Coppa and A. Roda, 2010. Cell-based assays: Fuelling drug discovery. Anal. Bioanal. Chem., 398: 227-238.
CrossRefDirect Link - Moore, K. and S. Rees, 2001. Cell-based versus isolated target screening: How lucky do you feel? J. Biomol. Screening, 6: 69-74.
CrossRefDirect Link - Zhang, J.H., T.D.Y. Chung and K.R. Oldenburg, 1999. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen., 4: 67-73.
CrossRefDirect Link - Stables, J., L.C. Mattheakis, R. Chang and S. Rees, 2000. Recombinant aequorin as reporter of changes in intracellular calcium in mammalian cells. Methods Enzymol., 327: 456-471.
CrossRefDirect Link - Schmidt, B.J., J.A. Papin and C.J. Musante, 2013. Mechanistic systems modeling to guide drug discovery and development. Drug Discov. Today, 18: 116-127.
CrossRefDirect Link - Maqbool, F., M. Safavi, H. Bahadar, M. Rahimifard, K. Niaz and M. Abdollahi, 2015. Discovery approaches for novel dyslipidemia drugs. Curr. Drug Discov. Technol., 12: 90-116.
Direct Link - Burkhard, J.A., G. Wuitschik, M. Rogers-Evans, K. Muller and E.M. Carreira, 2010. Oxetanes as versatile elements in drug discovery and synthesis. Angewandte Chemie Int. Edn., 49: 9052-9067.
CrossRefDirect Link - Dai, H.X., A.F. Stepan, M.S. Plummer, Y.H. Zhang and J.Q. Yu, 2011. Divergent C-H functionalizations directed by sulfonamide pharmacophores: Late-stage diversification as a tool for drug discovery. J. Am. Chem. Soc., 133: 7222-7228.
CrossRefDirect Link - Leach, A.G., H.D. Jones, D.A. Cosgrove, P.W. Kenny and L. Ruston et al., 2006. Matched molecular pairs as a guide in the optimization of pharmaceutical properties; a study of aqueous solubility, plasma protein binding and oral exposure. J. Med. Chem., 49: 6672-6682.
CrossRefDirect Link - Keefer, C.E., G. Chang and G.W. Kauffman, 2011. Extraction of tacit knowledge from large ADME data sets via pairwise analysis. Bioorg. Med. Chem., 19: 3739-3749.
CrossRefDirect Link - Friesner, R.A., R.B. Murphy, M.P. Repasky, L.L. Frye and J.R. Greenwood et al., 2006. Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J. Med. Chem., 49: 6177-6196.
CrossRefDirect Link - Newman, D.J. and G.M. Cragg, 2012. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod., 75: 311-335.
CrossRefDirect Link - Bauer, A. and M. Bronstrup, 2014. Industrial natural product chemistry for drug discovery and development. Nat. Prod. Rep., 31: 35-60.
CrossRefDirect Link - Ritchie, T.J. and S.J.F. Macdonald, 2009. The impact of aromatic ring count on compound developability-are too many aromatic rings a liability in drug design? Drug Discov. Today, 14: 1011-1020.
CrossRefDirect Link - Lovering, F., J. Bikker and C. Humblet, 2009. Escape from flatland: Increasing saturation as an approach to improving clinical success. J. Med. Chem., 52: 6752-6756.
CrossRefDirect Link - Stepan, A.F., G.W. Kauffman, C.E. Keefer, P.R. Verhoest and M. Edwards, 2013. Evaluating the differences in cycloalkyl ether metabolism using the design parameter lipophilic metabolism efficiency (LipMetE) and a matched molecular pairs analysis. J. Med. Chem., 56: 6985-6990.
CrossRefDirect Link - Stepan, A.F., K. Karki, W.S. McDonald, P.H. Dorff and J.K. Dutra et al., 2011. Metabolism-directed design of oxetane-containing arylsulfonamide derivatives as γ-secretase inhibitors. J. Med. Chem., 54: 7772-7783.
CrossRefDirect Link - Muller, K., C. Faeh and F. Diederich, 2007. Fluorine in pharmaceuticals: Looking beyond intuition. Science, 317: 1881-1886.
CrossRefDirect Link - Hernandes, M.Z., S.M.T. Cavalcanti, D.R.M. Moreira, W.F. de Azevedo Jr. and A.C.L. Leite, 2010. Halogen atoms in the modern medicinal chemistry: Hints for the drug design. Curr. Drug Targets, 11: 303-314.
CrossRefDirect Link - Schreiber, S.L., 2011. Organic synthesis toward small-molecule probes and drugs. Proc. Natl. Acad. Sci. USA., 108: 6699-6702.
CrossRefDirect Link - Nicolaou, K.C., C.R. Hale, C. Nilewski and H.A. Ioannidou, 2012. Constructing molecular complexity and diversity: Total synthesis of natural products of biological and medicinal importance. Chem. Soc. Rev., 41: 5185-5238.
CrossRefDirect Link - Sellers, W.R., 2011. A blueprint for advancing genetics-based cancer therapy. Cell, 147: 26-31.
CrossRefDirect Link - Nicolaou, K.C., 2014. Advancing the drug discovery and development process. Angewandte Chemie Int. Edn., 53: 9128-9140.
CrossRefDirect Link - Williams, S.A., W.C. Anderson, M.T. Santaguida and S.J. Dylla, 2013. Patient-derived xenografts, the cancer stem cell paradigm and cancer pathobiology in the 21st century. Lab. Invest., 93: 970-982.
CrossRefDirect Link - De Palma, M. and D. Hanahan, 2012. The biology of personalized cancer medicine: Facing individual complexities underlying hallmark capabilities. Mol. Oncol., 6: 111-127.
CrossRefDirect Link - Slusher, B.S., P.J. Conn, S. Frye, M. Glicksman and M. Arkin, 2013. Bringing together the academic drug discovery community. Nat. Rev. Drug Discov., 12: 811-812.
CrossRefDirect Link - Paul, S.M., D.S. Mytelka, C.T. Dunwiddie, C.C. Persinger, B.H. Munos, S.R. Lindborg and A.L. Schacht, 2010. How to improve R&D productivity: The pharmaceutical industry's grand challenge. Nat. Rev. Drug Discov., 9: 203-214.
CrossRefDirect Link

Muhammad Ahmad Reply
very effective